Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gene Therapy for Parkinson’s Disease, An Update
Tobias Melton Axelsen, David P.D. Woldbye
Journal of Parkinson s Disease (2018) Vol. 8, Iss. 2, pp. 195-215
Open Access | Times Cited: 147

Showing 1-25 of 147 citing articles:

Applications of focused ultrasound in the brain: from thermoablation to drug delivery
Ying Meng, Kullervo Hynynen, Nir Lipsman
Nature Reviews Neurology (2020) Vol. 17, Iss. 1, pp. 7-22
Closed Access | Times Cited: 326
The future of stem cell therapies for Parkinson disease
Malin Parmar, Shane Grealish, Claire Henchcliffe
Nature reviews. Neuroscience (2020) Vol. 21, Iss. 2, pp. 103-115
Closed Access | Times Cited: 262
The Nrf2-NLRP3-caspase-1 axis mediates the neuroprotective effects of Celastrol in Parkinson's disease
Chenyu Zhang, Miao Zhao, Bingwei Wang, et al.
Redox Biology (2021) Vol. 47, pp. 102134-102134
Open Access | Times Cited: 118
Lysosomal Dysfunction at the Centre of Parkinson’s Disease and Frontotemporal Dementia/Amyotrophic Lateral Sclerosis
Rebecca L. Wallings, Stewart W. Humble, Michael E. Ward, et al.
Trends in Neurosciences (2019) Vol. 42, Iss. 12, pp. 899-912
Open Access | Times Cited: 116
Current Advances in The Development of Novel Polymeric Nanoparticles for The Treatment of Neurodegenerative Diseases
Amanda Cano, Elena Sánchez‐López, Miren Ettcheto, et al.
Nanomedicine (2020) Vol. 15, Iss. 12, pp. 1239-1261
Open Access | Times Cited: 108
Strategies for the Treatment of Parkinson’s Disease: Beyond Dopamine
Alexandre Iarkov, George E. Barreto, J. Alex Grizzell, et al.
Frontiers in Aging Neuroscience (2020) Vol. 12
Open Access | Times Cited: 103
Promising drug targets and associated therapeutic interventions in Parkinson’s disease
Sachchida Nand, Payal Singh, Ritu Varshney, et al.
Neural Regeneration Research (2021) Vol. 16, Iss. 9, pp. 1730-1730
Open Access | Times Cited: 85
Bone Marrow Mesenchymal Stem Cells' Secretome Exerts Neuroprotective Effects in a Parkinson's Disease Rat Model
Bárbara Mendes-Pinheiro, Sandra I. Anjo, Bruno Manadas, et al.
Frontiers in Bioengineering and Biotechnology (2019) Vol. 7
Open Access | Times Cited: 83
Current Therapies in Clinical Trials of Parkinson’s Disease: A 2021 Update
E. Maruthi Prasad, Shih‐Ya Hung
Pharmaceuticals (2021) Vol. 14, Iss. 8, pp. 717-717
Open Access | Times Cited: 82
Novel targeted therapies for Parkinson’s disease
Theodora Ntetsika, Paraskevi-Evita Papathoma, Ioanna Markaki
Molecular Medicine (2021) Vol. 27, Iss. 1
Open Access | Times Cited: 78
The Prion-Like Spreading of Alpha-Synuclein in Parkinson’s Disease: Update on Models and Hypotheses
Asad Jan, Nádia Pereira Gonçalves, Christian B. Vægter, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 8338-8338
Open Access | Times Cited: 77
Current and Future Prospects for Gene Therapy for Rare Genetic Diseases Affecting the Brain and Spinal Cord
Thomas Leth Jensen, Casper R. Gøtzsche, David P.D. Woldbye
Frontiers in Molecular Neuroscience (2021) Vol. 14
Open Access | Times Cited: 60
Closing the loop for patients with Parkinson disease: where are we?
Hazhir Teymourian, Farshad Tehrani, Katherine Longardner, et al.
Nature Reviews Neurology (2022) Vol. 18, Iss. 8, pp. 497-507
Closed Access | Times Cited: 50
Lipid-Based Nanocarriers for Neurological Disorders: A Review of the State-of-the-Art and Therapeutic Success to Date
Bwalya A. Witika, Madan Poka, Patrick H. Demana, et al.
Pharmaceutics (2022) Vol. 14, Iss. 4, pp. 836-836
Open Access | Times Cited: 45
Delivering the Promise of Gene Therapy with Nanomedicines in Treating Central Nervous System Diseases
Meihua Luo, Leo Kit Cheung Lee, Bo Peng, et al.
Advanced Science (2022) Vol. 9, Iss. 26
Open Access | Times Cited: 43
Current Status and Future Perspectives on Stem Cell-Based Therapies for Parkinson’s Disease
Young Cha, Tae Yoon Park, Pierre Leblanc, et al.
Journal of Movement Disorders (2023) Vol. 16, Iss. 1, pp. 22-41
Open Access | Times Cited: 26
A Comprehensive Approach to Parkinson’s Disease: Addressing Its Molecular, Clinical, and Therapeutic Aspects
Mauricio Muleiro Álvarez, Gabriela Cano-Herrera, María Fernanda Osorio Martínez, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7183-7183
Open Access | Times Cited: 15
Adeno-Associated Virus Vector for Central Nervous System Gene Therapy
Danqing Zhu, Adam J. Schieferecke, Paola A. Lopez, et al.
Trends in Molecular Medicine (2021) Vol. 27, Iss. 6, pp. 524-537
Closed Access | Times Cited: 48
CRISPR-Cas9-Based Technology and Its Relevance to Gene Editing in Parkinson’s Disease
Mujeeb Ur Rahman, Muhammad Bilal, Junaid Ali Shah, et al.
Pharmaceutics (2022) Vol. 14, Iss. 6, pp. 1252-1252
Open Access | Times Cited: 36
Multifunctional role of natural products for the treatment of Parkinson’s disease: At a glance
Md. Mominur Rahman, Xiaoyan Wang, Md. Rezaul Islam, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 28
Aicardi–Goutières syndrome: A monogenic type I interferonopathy
Anran Liu, Songcheng Ying
Scandinavian Journal of Immunology (2023) Vol. 98, Iss. 4
Open Access | Times Cited: 22
Advances in nanotechnology-assisted photodynamic therapy for neurological disorders: a comprehensive review
Abdul Nasır, Mujeeb ur Rehman, Tamreez Khan, et al.
Artificial Cells Nanomedicine and Biotechnology (2024) Vol. 52, Iss. 1, pp. 84-103
Open Access | Times Cited: 7
Nanomaterials for Parkinson disease: Recent progress
Esraa Ghazy, Abbas Rahdar, Mahmood Barani, et al.
Journal of Molecular Structure (2020) Vol. 1231, pp. 129698-129698
Closed Access | Times Cited: 47
Challenges in adeno-associated virus-based treatment of central nervous system diseases through systemic injection
Lan Huang, Jie Wan, Yinqiu Wu, et al.
Life Sciences (2021) Vol. 270, pp. 119142-119142
Open Access | Times Cited: 37
Nanoparticle-Guided Brain Drug Delivery: Expanding the Therapeutic Approach to Neurodegenerative Diseases
Claudia Riccardi, Filomena Napolitano, Daniela Montesarchio, et al.
Pharmaceutics (2021) Vol. 13, Iss. 11, pp. 1897-1897
Open Access | Times Cited: 35
Page 1 - Next Page

Scroll to top